Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Probe ablation as salvage therapy for renal tumors in von Hippel-Lindau patients: the Cleveland Clinic experience with 3 years follow-up.

Yang B, Autorino R, Remer EM, Laydner HK, Hillyer S, Altunrende F, White MA, Khanna R, Stein RJ, Haber GP, O'Malley CM, Kaouk JH.

Urol Oncol. 2013 Jul;31(5):686-92. doi: 10.1016/j.urolonc.2011.05.008. Epub 2011 Jul 2.

PMID:
21723752
2.

Percutaneous renal cryoablation of renal tumors in patients with von Hippel-Lindau disease.

Shingleton WB, Sewell PE Jr.

J Urol. 2002 Mar;167(3):1268-70.

PMID:
11832711
3.

Percutaneous radio frequency ablation of renal tumors in patients with von Hippel-Lindau disease: preliminary results.

Park BK, Kim CK.

J Urol. 2010 May;183(5):1703-7. doi: 10.1016/j.juro.2010.01.022. Epub 2010 Mar 17.

PMID:
20299060
4.

Management of renal tumors in Von Hippel-Lindau disease by percutaneous CT fluoroscopic guided radiofrequency ablation: preliminary results.

Iwamoto Y, Kanda H, Yamakado K, Soga N, Arima K, Takeda K, Sugimura Y.

Fam Cancer. 2011 Sep;10(3):529-34. doi: 10.1007/s10689-011-9440-3.

PMID:
21503747
5.

Percutaneous radiofrequency ablation of renal cell carcinomas in patients with von Hippel Lindau disease: indications, techniques, complications, and outcomes.

Park BK, Kim CK, Park SY, Shen SH.

Acta Radiol. 2013 May;54(4):418-27. doi: 10.1177/0284185113475441. Epub 2013 Apr 30. Review.

PMID:
23446745
6.

Retroperitoneoscopic-guided radiofrequency ablation of renal tumors.

Pautler SE, Pavlovich CP, Mikityansky I, Drachenberg DE, Choyke PL, Linehan WM, Wood BJ, Walther MM.

Can J Urol. 2001 Aug;8(4):1330-3.

PMID:
11564277
7.

Percutaneous cryoablation of anterior renal masses: technique, efficacy, and safety.

Schmit GD, Atwell TD, Leibovich BC, Callstrom MR, Kurup AN, Woodrum DA, Charboneau JW.

AJR Am J Roentgenol. 2010 Dec;195(6):1418-22. doi: 10.2214/AJR.09.3530.

PMID:
21098204
8.

Percutaneous radiofrequency ablation with contrast-enhanced ultrasonography for solitary and sporadic renal cell carcinoma in patients with autosomal dominant polycystic kidney disease.

Xu L, Rong Y, Wang W, Lian H, Gan W, Yan X, Li X, Guo H.

World J Surg Oncol. 2016 Jul 26;14(1):193. doi: 10.1186/s12957-016-0916-3.

9.

Probe-ablative nephron-sparing surgery: cryoablation versus radiofrequency ablation.

Hegarty NJ, Gill IS, Desai MM, Remer EM, O'Malley CM, Kaouk JH.

Urology. 2006 Jul;68(1 Suppl):7-13.

PMID:
16857454
10.

Patterns of intervention for renal lesions in von Hippel-Lindau disease.

Matin SF, Ahrar K, Wood CG, Daniels M, Jonasch E.

BJU Int. 2008 Sep;102(8):940-5. doi: 10.1111/j.1464-410X.2008.07718.x. Epub 2008 May 15.

11.

Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.

Thompson RH, Atwell T, Schmit G, Lohse CM, Kurup AN, Weisbrod A, Psutka SP, Stewart SB, Callstrom MR, Cheville JC, Boorjian SA, Leibovich BC.

Eur Urol. 2015 Feb;67(2):252-9. doi: 10.1016/j.eururo.2014.07.021. Epub 2014 Aug 6.

PMID:
25108580
12.

[Radiofrequency ablation for recurred renal cell carcinoma in the solitary kidney due to von Hippel-Lindau disease--indication and tip on how to prevent the thermal injury of the adjacent organs].

Anai H, Nagata T, Sato T, Minoshima K, Horie M, Yoshiya K, Uchida H, Kichikawa K.

Gan To Kagaku Ryoho. 2010 Nov;37(12):2303-5. Japanese.

PMID:
21224555
13.

Percutaneous cryoablation of masses in a solitary kidney.

Weisbrod AJ, Atwell TD, Frank I, Callstrom MR, Farrell MA, Mandrekar JN, Charboneau JW.

AJR Am J Roentgenol. 2010 Jun;194(6):1620-5. doi: 10.2214/AJR.09.2978.

PMID:
20489104
14.

Cancer-free survival and local tumor control after impendence-based radiofrequency ablation of biopsy-proven renal cell carcinomas with a minimum of 1-year follow-up.

Forauer AR, Dewey BJ, Seigne JD.

Urol Oncol. 2014 Aug;32(6):869-76. doi: 10.1016/j.urolonc.2014.03.016. Epub 2014 Jun 16.

PMID:
24946958
15.

Real-time magnetic resonance imaging-guided cryoablation of small renal tumors at 1.5 T.

Ahrar K, Ahrar JU, Javadi S, Pan L, Milton DR, Wood CG, Matin SF, Stafford RJ.

Invest Radiol. 2013 Jun;48(6):437-44. doi: 10.1097/RLI.0b013e31828027c2.

16.

Salvage Percutaneous Cryoablation for Locally Recurrent Renal-Cell Carcinoma After Primary Cryoablation.

Okhunov Z, Chamberlin J, Moreira DM, George A, Babaian K, Shah P, Youssef R, Kaler KS, Lobko II, Kavoussi L, Landman J.

J Endourol. 2016 Jun;30(6):632-7. doi: 10.1089/end.2016.0088. Epub 2016 Apr 22.

PMID:
27009377
17.

Percutaneous radiofrequency ablation of renal cell carcinomas in patients with von Hippel Lindau disease previously undergoing a radical nephrectomy or repeated nephron-sparing surgery.

Park SY, Park BK, Kim CK, Lee HM, Jeon SS, Seo SI, Jeong BC, Choi HY.

Acta Radiol. 2011 Jul 1;52(6):680-5. doi: 10.1258/ar.2011.100435. Epub 2011 Apr 27.

PMID:
21525107
18.

[Clinical study on patients with renal-cell carcinoma accompanied with Von Hippel-Lindau disease treated with radiofrequency ablation].

Nao T, Shimamoto T, Karashima T, Kamei M, Fukuhara H, Fukata S, Satake H, Ashida S, Yamasaki I, Kamata M, Inoue K, Yamanishi T, Ogawa Y, Ito S, Shuin T.

Hinyokika Kiyo. 2014 Sep;60(9):415-20. Japanese.

19.

Percutaneous cryoablation of renal masses >or=3 cm: efficacy and safety in treatment of 108 patients.

Schmit GD, Atwell TD, Callstrom MR, Farrell MA, Leibovich BC, Patterson DE, Chow GK, Blute ML, Charboneau JW.

J Endourol. 2010 Aug;24(8):1255-62. doi: 10.1089/end.2009.0328.

PMID:
20380510
20.

Percutaneous cryoablation of solitary sporadic renal cell carcinomas.

Schmit GD, Thompson RH, Kurup AN, Weisbrod AJ, Carter RE, Callstrom MR, Atwell TD.

BJU Int. 2012 Dec;110(11 Pt B):E526-31. doi: 10.1111/j.1464-410X.2012.11230.x. Epub 2012 May 15.

Supplemental Content

Support Center